
Yuval Shaked
@shakedyuval
We will find the way to defeat cancer
ID: 1038552855051952128
http://shakedlab.net.technion.ac.il 08-09-2018 22:21:10
191 Tweet
143 Followers
96 Following


So many great talks over the last few days, including fab work from CRUK Cambridge Institute sister institutes CRUK Scotland Inst Sara Zanivan, CRUK Manchester Institute Santiago Zelenay and The Francis Crick Institute eriksahailab (here in his role as chair as I forgot to take a photo during his talk 😅).



Thanks The Cancer Letter for sharing our JCO Precision Oncology publication news! Serving as a composite #biomarker with PD-L1 testing, PROphet® NSCLC optimizes treatment selection, improving OS and potentially reducing #chemo-related toxicity in some #patients. bit.ly/49qbTWG

I was honored to receive today the Kadar Award for Outstanding Reseach. This was made possible by my amazing students, past and present that push together our ideas and discoveries. Science is a team effort. Thank you very much! TAU Gray Faculty of Medical & Health Sciences אוניברסיטת תל אביב Tel Aviv University






In the August issue: The Interplay Between #ExtracellularMatrix Remodeling and Cancer Therapeutics. bit.ly/3M91iX0 Jai Prakash Yuval Shaked University of Twente (inactive) Technion Israel.


Honored and excited to become President of the Israeli Society for Cancer Research ISCR- The Israeli Society for Cancer Research together with Vice President Yuval Shaked. Thank you Cyrille Cohen for your leadership and friendship! 💐 Looking forward to continue and advance the cancer research comminity in Israel!


Dr. Ernesto Bustinza-Linares & Dr. Lucio N. Gordan of #FCS discuss our recent @JCOPO study with OncLive.com and stress the impact of precision medicine on patient outcomes Read more: bit.ly/4g4uyeW #PrecisionMedicine #OncologyResearch #NSCLC





What a great first day of the NanoTME 2025 Meeting (nanotme.nl) organized by Jai Prakash and Yuval Shaked including inspiring talks by Assaf Zinger on biomimetic #nanoparticles and Dan Peer on #LNP enabling nucleic acid therapeutics!
